Endeavour Silver Corp vs Liquidia Corporation Common Stock — how do they compare? Endeavour Silver Corp trades at $8 (market cap $2.32B), while Liquidia Corporation Common Stock trades at $34.2 (market cap $3.04B). The key difference: Liquidia Corporation Common Stock is the larger of the two by market cap, and Liquidia Corporation Common Stock is more actively traded (21,111,778 versus 8,976,489). Which is the better fit depends on your goals — on Pluang, investors hold Endeavour Silver Corp for 26 Days and Liquidia Corporation Common Stock for 0 Days on average.
| EXK | LQDA | |
|---|---|---|
Market Cap | $2.32B | $3.04B |
Volume | 8,976,489 | 21,111,778 |
Sector | Basic Materials | Health |
52-Week High | $14.12 | $91.03 |
52-Week Low | $7.07 | $22.02 |
Typical Hold Time | 26 Days | 0 Days |
Enterprise Value | $2.32B | $2.94B |
Signals from Pluang's Aura AI — not financial advice
Endeavour Silver (EXK) trades at $8.24, down 3.51% today amid bearish technical signals. The company shows improving fundamentals with Q1 2026 earnings beating expectations and strong revenue growth projected for 2026. Recent news highlights operational progress at Terronera and Kolpa mines, though mechanical issues at Guanacevi and past blockades present challenges. Analyst sentiment remains predominantly bullish with 78.57% buy ratings.
EXK presents a growth story with expanding production capacity but faces execution risks. The stock's valuation appears elevated with a P/E of 39.15, requiring continued operational success to justify. Near-term catalysts include Terronera mine ramp-up and silver price movements, while operational disruptions and commodity volatility remain key risks for investors.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Endeavour Silver is a mid-tier precious metals mining company. It operates silver-gold mines in Mexico and is focused on growing its production and reserves through exploration and the development of new mining projects.
Read more on EXK →Liquidia Corporation is a biopharmaceutical company that develops therapies for rare cardiopulmonary diseases, including YUTREPIA, an inhaled treprostinil powder for pulmonary hypertension built on its PRINT technology.
Read more on LQDA →